2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione Mediates the Effect of ROS-enhanced PI3K/Akt/mTOR Pathway on Autophagy in Breast Cancer

Overview

Journal FEBS Open Bio

Specialty Biology

Date 2024 Dec 9

PMID 39648951

Authors

Linqian Chen

Meifeng Chen

Yan Xie

Yuyan Zhang

Shutian Mo

Yongfei He

Tianyi Liang

Yuan Liao

Renbin Huang

Guodong Huang

Chuangye Han

Thi Thai Hoa Pham

Affiliations

Soon will be listed here.

Abstract

Several studies have suggested a potential antitumor effect of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione (DMDD). To further understand the mechanism of action of this compound, we investigated its effect on the phosphatidylinositol-3-kinase (PI3K)/serine-threonine kinase (Akt)/mammalian target of rapamycin (mTOR) signaling pathway. We show that DMDD application significantly inhibited the proliferation of breast cancer cell lines MDA-MB-231 and ER-α positive MCF-7. Furthermore, DMDD application resulted in increased intracellular reactive oxygen species (ROS) levels, apoptosis and autophagy, whereas it downregulated the expression of PI3K, Akt and mTOR mRNA and proteins, and increased the expression of LC3II/I and p62 proteins. In a mouse breast cancer xenograft model, DMDD inhibited tumor growth. Expression analyses suggest that ROS levels were higher in DMDD treated tumor tissues, whereas immunohistochemical analyses suggest that apoptotic cells were more prevalent in the DMDD treated group compared to the control group. Taken together, our results suggest that the molecular mechanism of action of DMDD may involve the enhancement of breast cancer autophagy through the PI3K/Akt/mTOR signaling pathway by mediating ROS expression.

References

Strohecker A, Guo J, Karsli-Uzunbas G, Price S, Chen G, Mathew R . Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors. Cancer Discov. 2013; 3(11):1272-85. PMC: 3823822. DOI: 10.1158/2159-8290.CD-13-0397. View

Zhao S, Chen M, Yu Z, Pham T, Mo S, He Y . Biomimetic cytomembrane-coated ZIF-8-loaded DMDD nanoparticle and sonodynamic co-therapy for cancer. Ann Transl Med. 2022; 10(18):971. PMC: 9577741. DOI: 10.21037/atm-22-3646. View

Dikic I, Elazar Z . Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018; 19(6):349-364. DOI: 10.1038/s41580-018-0003-4. View

Galluzzi L, Green D . Autophagy-Independent Functions of the Autophagy Machinery. Cell. 2019; 177(7):1682-1699. PMC: 7173070. DOI: 10.1016/j.cell.2019.05.026. View

Zhao X, Wei S, Li Z, Lin C, Zhu Z, Sun D . Autophagic flux blockage in alveolar epithelial cells is essential in silica nanoparticle-induced pulmonary fibrosis. Cell Death Dis. 2019; 10(2):127. PMC: 6372720. DOI: 10.1038/s41419-019-1340-8. View

Li J, Wei X, Xie Q, Pham T, Wei J, He P . Protective Effects of 2-Dodecyl-6-Methoxycyclohexa-2,5 -Diene-1,4-Dione Isolated from Averrhoa Carambola L. (Oxalidaceae) Roots on High-Fat Diet-Induced Obesity and Insulin Resistance in Mice. Cell Physiol Biochem. 2016; 40(5):993-1004. DOI: 10.1159/000453156. View

Siegel R, Giaquinto A, Jemal A . Cancer statistics, 2024. CA Cancer J Clin. 2024; 74(1):12-49. DOI: 10.3322/caac.21820. View

Wei T, Xiaojun X, Peilong C . Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways. Biomed Pharmacother. 2019; 121:109139. DOI: 10.1016/j.biopha.2019.109139. View

Silva A, Girio A, Cebola I, Santos C, Antunes F, Barata J . Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells. Leukemia. 2011; 25(6):960-7. DOI: 10.1038/leu.2011.56. View

10.

Rosenfeldt M, OPrey J, Morton J, Nixon C, Mackay G, Mrowinska A . p53 status determines the role of autophagy in pancreatic tumour development. Nature. 2013; 504(7479):296-300. DOI: 10.1038/nature12865. View

11.

Braicu C, Zanoaga O, Zimta A, Tigu A, Kilpatrick K, Bishayee A . Natural compounds modulate the crosstalk between apoptosis- and autophagy-regulated signaling pathways: Controlling the uncontrolled expansion of tumor cells. Semin Cancer Biol. 2020; 80:218-236. DOI: 10.1016/j.semcancer.2020.05.015. View

12.

Rao S, Tortola L, Perlot T, Wirnsberger G, Novatchkova M, Nitsch R . A dual role for autophagy in a murine model of lung cancer. Nat Commun. 2014; 5:3056. DOI: 10.1038/ncomms4056. View

13.

Hanahan D . Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022; 12(1):31-46. DOI: 10.1158/2159-8290.CD-21-1059. View

14.

Gao Y, Huang R, Gong Y, Park H, Wen Q, Marwan Almosnid N . The antidiabetic compound 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione, isolated from Averrhoa carambola L., demonstrates significant antitumor potential against human breast cancer cells. Oncotarget. 2015; 6(27):24304-19. PMC: 4695187. DOI: 10.18632/oncotarget.4475. View

15.

Gan S, Macalinao D, Shahoei S, Tian L, Jin X, Basnet H . Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain. Cancer Cell. 2024; 42(10):1693-1712.e24. DOI: 10.1016/j.ccell.2024.08.015. View

16.

Mulcahy Levy J, Thorburn A . Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients. Cell Death Differ. 2019; 27(3):843-857. PMC: 7206017. DOI: 10.1038/s41418-019-0474-7. View

17.

Zou Z, Tao T, Li H, Zhu X . mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Biosci. 2020; 10:31. PMC: 7063815. DOI: 10.1186/s13578-020-00396-1. View

18.

Pei X, Xiao J, Wei G, Zhang Y, Lin F, Xiong Z . Oenothein B inhibits human non-small cell lung cancer A549 cell proliferation by ROS-mediated PI3K/Akt/NF-κB signaling pathway. Chem Biol Interact. 2018; 298:112-120. DOI: 10.1016/j.cbi.2018.09.021. View

19.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

20.

Araki K, Miyoshi Y . Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer. Breast Cancer. 2017; 25(4):392-401. DOI: 10.1007/s12282-017-0812-x. View